EUVIMEDEUVIMED entdecken
Crossref

Matrix stiffness promotes corneal fibrosis through the YAP/TAZ–β-catenin mechanotransduction pathway: Proteomic and functional validation

Kexin Li, Hui Fu, Lijie Miao, Yang Lu, Charong He, Yuanyuan Liu, Zhongli Hu, Bintao Xie, Xiujuan Lv, Fan Lu, Meng Lin, Liang Hu

Acta Biomaterialia · 2026-06 · 216 · 215-233

DOI: 10.1016/j.actbio.2026.04.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Biomaterialia, 2026-06. Verfasst von Kexin Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China; State Key Laboratory of Eye H…. Hauptthemen laut MEDLINE: beta Catenin, Mechanotransduction, Cellular, Extracellular Matrix, Proteomics. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Corneal fibrosis, a major cause of corneal opacification and vision loss, is characterized by a progressive increase in extracellular matrix (ECM) stiffness. This heightened stiffness accelerates fibrosis, establishing a self-perpetuating vicious cycle. However, the central mechanotransduction mechanisms through which matrix stiffness drives fibrotic progression remain poorly understood. To investigate this, primary human corneal fibroblasts were cultured on hydrogels with varying stiffness. Label-free quantitative proteomics revealed that increased ECM stiffness triggered widespread proteomic reprogramming, with significant enrichment in pathways related to fibrosis, Hippo signaling, cytoskeletal remodeling, and glycolysis. Further experimental validation confirmed that matrix stiffness coordinately activated the Hippo pathway effectors YAP/TAZ (Yes-associated protein 1/Transcriptional coactivator with PDZ-binding motif) and the canonical Wnt component β-catenin. Importantly, in human fibrotic corneal tissues obtained from clinical specimens, YAP and β-catenin were highly expressed and spatially co-localized with the myofibroblast marker alpha-smooth muscle actin (α-SMA). Modulation of the YAP/TAZ-β-catenin axis through genetic silencing (siRNA) and pharmacological approaches, including pathway inhibitors and agonists, significantly altered stiffness-induced fibrotic phenotypes. Mechanistic studies revealed that YAP/TAZ functioned as key mechanotransducers upstream of β-catenin, and that YAP and β-catenin physically interacted. Collectively, this work identifies the YAP/TAZ-β-catenin pathway as one of the key mechanotransduction pathways of stiffness-induced corneal fibrosis. These findings not only deepen our understanding of the biomechanical mechanisms underlying fibrosis but also provide a mechanistic rationale for developing anti-fibrotic biomaterials and therapies that target mechanical sensing. STATEMENT OF SIGNIFICANCE: This study identifies the YAP/TAZ-β-catenin axis as one of the key mechanotransduction pathways in stiffness-driven corneal fibrosis. Label-free quantitative proteomics revealed widespread protein expression alterations in primary human corneal fibroblasts subjected to pathological matrix stiffness. Pharmacological and genetic perturbations confirmed that YAP/TAZ acts upstream of β-catenin to promote myofibroblast differentiation, supported by evidence of direct protein-protein interaction and co-localization of YAP and β-catenin in fibrotic human corneal tissue. These findings highlight the importance of the mechanical microenvironment in corneal fibrosis beyond classical biochemical stimuli and suggest that targeting this pathway may offer a therapeutic strategy for corneal fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta CateninMechanotransduction, CellularExtracellular MatrixProteomicsCorneaAdaptor Proteins, Signal TransducingTranscription FactorsPhosphoproteinsHumansYAP-Signaling ProteinsFibrosisTrans-ActivatorsFibroblasts

Stichwörter der Autor:innen

Corneal fibrosisMatrix stiffnessMechanotransductionYAP/TAZβ-catenin

Substanzen

beta CateninYAP-Signaling ProteinsAdaptor Proteins, Signal TransducingTranscription FactorsYAP1 protein, humanTrans-ActivatorsPhosphoproteins

Autor:innen und Institutionen

  • National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China; State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China…
  • State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Li, K., Fu, H., Miao, L., Lu, Y., He, C., Liu, Y., Hu, Z., Xie, B., Lv, X., Lu, F., Lin, M., & Hu, L. (2026). Matrix stiffness promotes corneal fibrosis through the YAP/TAZ–β-catenin mechanotransduction pathway: Proteomic and functional validation. Acta Biomaterialia, 216, 215-233. https://doi.org/10.1016/j.actbio.2026.04.021

Vancouver

Li K, Fu H, Miao L, Lu Y, He C, Liu Y, et al. Matrix stiffness promotes corneal fibrosis through the YAP/TAZ–β-catenin mechanotransduction pathway: Proteomic and functional validation. Acta Biomaterialia. 2026;216:215-233. doi:10.1016/j.actbio.2026.04.021

BibTeX
@article{Li2026,
  author = {Li, Kexin and Fu, Hui and Miao, Lijie and Lu, Yang and He, Charong and Liu, Yuanyuan and Hu, Zhongli and Xie, Bintao and Lv, Xiujuan and Lu, Fan and Lin, Meng and Hu, Liang},
  title = {Matrix stiffness promotes corneal fibrosis through the YAP/TAZ–β-catenin mechanotransduction pathway: Proteomic and functional validation},
  journal = {Acta Biomaterialia},
  year = {2026},
  volume = {216},
  pages = {215--233},
  doi = {10.1016/j.actbio.2026.04.021}
}
Kostenlos starten →